|
Volumn 104, Issue 5 PART 2, 2004, Pages 1134-1136
|
Retroperitoneal fibrosis secondary to actinomycosis with no intrauterine device
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIFUNGAL AGENT;
ANTIINFECTIVE AGENT;
ABDOMINAL PAIN;
ABSCESS;
ACTINOMYCES;
ACTINOMYCOSIS;
ADULT;
ARTICLE;
CASE REPORT;
COMPUTER ASSISTED TOMOGRAPHY;
FEMALE;
FOLLOW UP;
HOSPITALIZATION;
HUMAN;
IMMUNOHISTOCHEMISTRY;
INTRAUTERINE CONTRACEPTIVE DEVICE;
ISOLATION AND PURIFICATION;
LAPAROTOMY;
METHODOLOGY;
MICROBIOLOGY;
MULTIMODALITY CANCER THERAPY;
NEEDLE BIOPSY;
OVARY INFLAMMATION;
PELVIC INFLAMMATORY DISEASE;
RETROPERITONEAL FIBROSIS;
RISK ASSESSMENT;
TREATMENT OUTCOME;
ABDOMINAL PAIN;
ABSCESS;
ACTINOMYCES;
ACTINOMYCOSIS;
ADULT;
ANTI-BACTERIAL AGENTS;
ANTIFUNGAL AGENTS;
BIOPSY, NEEDLE;
COMBINED MODALITY THERAPY;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
IMMUNOHISTOCHEMISTRY;
INTRAUTERINE DEVICES;
LAPAROTOMY;
OOPHORITIS;
PELVIC INFLAMMATORY DISEASE;
RETROPERITONEAL FIBROSIS;
RISK ASSESSMENT;
SEVERITY OF ILLNESS INDEX;
TOMOGRAPHY, X-RAY COMPUTED;
TREATMENT OUTCOME;
|
EID: 16544392693
PISSN: 00297844
EISSN: 1873233X
Source Type: Journal
DOI: 10.1097/01.AOG.0000144118.90772.a1 Document Type: Article |
Times cited : (21)
|
References (7)
|